Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cisplatin-related Hearing Loss”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Testing effectiveness (Phase 2)WithdrawnNCT01451853
What this trial is testing

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

Who this might be right for
Lung CancerHead and Neck CancerHearing Loss+3 more
Sound Pharmaceuticals, Incorporated
Testing effectiveness (Phase 2)UnknownNCT01108601
What this trial is testing

Transtympanic Ringer's Lactate for the Prevention of Cisplatin Ototoxicity

Who this might be right for
Hearing Loss
McGill University Health Centre/Research Institute of the McGill University Health Centre 20
Not applicableStudy completedNCT02099786
What this trial is testing

Randomized Trial Comparison of Ototoxicity Monitoring Programs

Who this might be right for
Cisplatin OtotoxicityHearing Loss
VA Office of Research and Development 47
Not applicableStudy completedNCT03400709
What this trial is testing

Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer

Who this might be right for
Cisplatin Adverse ReactionHearing Loss Ototoxic
Hospital San Juan de Dios, Santiago 45
Not applicableLooking for participantsNCT05946577
What this trial is testing

Association Between Tinnitus and Hearing Loss in Locally Advanced Head and Neck Cancer Treated by Radiotherapy Alone or With Chemotherapy: a Prospective and Multicenter Study

Who this might be right for
Head CancerNeck Cancer
Assistance Publique - Hôpitaux de Paris 140
Not applicableUnknownNCT00578760
What this trial is testing

Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity?

Who this might be right for
Hearing LossOtotoxicity
University Health Network, Toronto 110
Testing effectiveness (Phase 2)Looking for participantsNCT07364747
What this trial is testing

Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial

Who this might be right for
Cisplatin-induced OtotoxicitySensorineural Hearing LossOtotoxicity+1 more
Siriraj Hospital 40
Large-scale testing (Phase 3)Looking for participantsNCT07281508
What this trial is testing

Transtympanic STS Against Cisplatin-induced SNHL: the SOUND Trial

Who this might be right for
Cisplatin-related Hearing Loss
The Netherlands Cancer Institute 100
Not applicableLooking for participantsNCT06551857
What this trial is testing

The Effect of Cancer Treatments on Speech Perception in Noise, Cognition, and Hearing-Related Quality of Life

Who this might be right for
CancerHearing Loss OtotoxicCognitive Decline+1 more
Turku University Hospital 250
Large-scale testing (Phase 3)Study completedNCT00477607
What this trial is testing

Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin

Who this might be right for
OtotoxicityUnspecified Adult Solid Tumor
US Department of Veterans Affairs 39
Post-approval studies (Phase 4)Study completedNCT01372904
What this trial is testing

Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment

Who this might be right for
Cisplatin Ototoxicity
Meir Medical Center 30
Post-approval studies (Phase 4)Ended earlyNCT04226456
What this trial is testing

Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity

Who this might be right for
Ototoxic Hearing LossOtotoxic Hearing Loss, BilateralOtotoxicity+1 more
Centre Hospitalier Universitaire Saint Pierre 19
Not applicableNot Yet RecruitingNCT07622407
What this trial is testing

Maximizing Quality of Life After Cancer Through Rehabilitation

Who this might be right for
Head and Neck CancerHearing LossTinnitus+1 more
VA Office of Research and Development 74
Not applicableWithdrawnNCT02382068
What this trial is testing

Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin

Who this might be right for
Malignant NeoplasmOtotoxicity
Aaron Moberly
Not applicableNot Yet RecruitingNCT06929468
What this trial is testing

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

Who this might be right for
Ototoxic Hearing LossOtotoxicity, Drug-InducedCisplatin-induced Hearing Loss+8 more
Simon Jäger 55
Testing effectiveness (Phase 2)Study completedNCT01139281
What this trial is testing

The Protective Effect of Ginkgo Biloba Extract on Cisplatin-induced Ototoxicity in Humans

Who this might be right for
OtotoxicityHearing Loss
University of Brasilia 15
Not applicableLooking for participantsNCT06662058
What this trial is testing

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Cutaneous Squamous Cell Carcinoma of the Head and NeckHead and Neck Carcinoma of Unknown Primary+30 more
Emory University 118
Not applicableStudy completedNCT05789316
What this trial is testing

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Who this might be right for
Head and Neck Cancer SurvivorsCancer of the Head and Neck Surviors
Washington University School of Medicine 55
Early research (Phase 1)Study completedNCT04262336
What this trial is testing

Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment

Who this might be right for
Ototoxicity
Decibel Therapeutics 22
Large-scale testing (Phase 3)Study completedNCT00716976
What this trial is testing

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Who this might be right for
Brain TumorCentral Nervous System TumorChildhood Germ Cell Tumor+6 more
Children's Oncology Group 131
Next Page